Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1802]
News [2707]
Articles [198]
Editorials [1]
Conferences [135]
elearning [13]
Gynaecological Cancers
Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK
Gynaecological Cancers ( Dr Susana Banerjee - The Royal Marsden NHS Foundation Trust, London, UK )
7 Nov 2023
GI cancers
Dr Tanvi Sood - Paras hospital, Gurugram, India
GI cancers ( Dr Tanvi Sood - Paras hospital, Gurugram, India )
7 Nov 2023
Lung Cancer
Dr Sabita Jiwnani - Tata Memorial Hospital, Mumbai, India
Lung Cancer ( Dr Sabita Jiwnani - Tata Memorial Hospital, Mumbai, India )
6 Nov 2023
Head and Neck Cancers
Dr Vijay Patil - Hinduja Hospital & Medical Research Centre, Mumbai
Head and Neck Cancers ( Dr Vijay Patil - Hinduja Hospital & Medical Research Centre, Mumbai )
6 Nov 2023
Breast Cancer
Dr Nita Nair - Apollo Cancer Centres, Mumbai
Breast Cancer ( Dr Nita Nair - Apollo Cancer Centres, Mumbai )
6 Nov 2023
Induction chemotherapy added to chemoradiation improves PFS and OS in advanced...
Dr Mary McCormack - University College Hospital, London, UK
Induction chemotherapy added to chemoradiation improves PFS and OS in advanced cervical cancer ( Dr Mary McCormack - University College Hospital, London, UK )
23 Oct 2023
Datopotamab deruxtecan extends PFS vs chemo for HR+/HER2- breast cancer
Dr Aditya Bardia - Mass General Cancer Center, Boston, USA
Datopotamab deruxtecan extends PFS vs chemo for HR+/HER2- breast cancer ( Dr Aditya Bardia - Mass General Cancer Center, Boston, USA )
23 Oct 2023
Nivolumab plus gemcitabine-cisplatin shows benefit for locally advanced mUC
Dr Michiel Van der Heijden - Netherlands Cancer Institute, Amsterdam...
Nivolumab plus gemcitabine-cisplatin shows benefit for locally advanced mUC ( Dr Michiel Van der Heijden - Netherlands Cancer Institute, Amsterdam, Netherlands )
22 Oct 2023
Belzutifan cabozantinib combo shows durable anti-tumour effect at phase II for...
Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA
Belzutifan cabozantinib combo shows durable anti-tumour effect at phase II for ccRCC ( Dr Toni Choueiri - Dana-Farber Cancer Institute, Boston, USA )
22 Oct 2023
ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC
Dr Joshua Sabari, Dr Enriqueta Felip and Dr Alex Spira
ESMO 2023: Latest in EGFR Ex20ins advanced NSCLC ( Dr Joshua Sabari, Dr Enriqueta Felip and Dr Alex Spira )
22 Oct 2023
A biomarker led approach to bladder cancer
Prof Andrea Necchi, Dr Guillermo De Velasco, Prof Arlene Siefker-Radtke and Dr...
A biomarker led approach to bladder cancer ( Prof Andrea Necchi, Dr Guillermo De Velasco, Prof Arlene Siefker-Radtke and Dr Yohann Loriot )
22 Oct 2023
Durvalumab addition to chemo shows endometrial cancer benefit
Prof Shannon Westin - University of Texas MD Anderson Cancer Center, Houston...
Durvalumab addition to chemo shows endometrial cancer benefit ( Prof Shannon Westin - University of Texas MD Anderson Cancer Center, Houston, USA )
21 Oct 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation